Anskaffelser: The Norwegian Institute of Public Health
2 arkiverte anskaffelser
The Norwegian Institute of Public Health har historisk anskaffet medisinsk utstyr, legemidler og utstyr til personlig pleie, farmasøytiske produkter og antiinfektive midler for systemisk bruk, vaksiner, cytostatika/cytotoxiske midler, samt immunmodulerende midler.
Nyeste anskaffelser av The Norwegian Institute of Public Health
2016-10-31
Data acquisition via telephone, web and SMS (The Norwegian Institute of Public Health)
The tenderer shall register water consumption and occurrences of gastroenteritus in a selection of the Norwegian population over the course of one year via a telephone interview (recruitment), web questionnaire and a monthly SMS questionnaire. The aim of the study is to get a better general picture of how drinking water contributes to illness in Norway. Better knowledge of the extent and reasons for infections spreading through drinking water can give a basis for prioritising disease preventive measures … Vis anskaffelsen »
The tenderer shall register water consumption and occurrences of gastroenteritus in a selection of the Norwegian population over the course of one year via a telephone interview (recruitment), web questionnaire and a monthly SMS questionnaire. The aim of the study is to get a better general picture of how drinking water contributes to illness in Norway. Better knowledge of the extent and reasons for infections spreading through drinking water can give a basis for prioritising disease preventive measures … Vis anskaffelsen »
2016-06-18
A combination vaccine against diphtheria, tetanus, whooping cough, polio, Hib and hepatitis B (The Norwegian Institute of Public Health)
The Norwegian Institute of Public Health shall enter into an agreement regarding the purchase of a combination vaccine for the diseases: diphtheria, whooping cough, tetanus, polio, Hib and hepatitis B (a 6 component vaccine), for the National Vaccine Programme. The 6 component vaccine shall replace the current 5 component vaccine (diphtheria, whooping cough, tetanus, polio and Hib) and partly vaccine against hepatitis B for defined risk groups. The procurement is carried out on behalf of the Norwegian … Vis anskaffelsen »
The Norwegian Institute of Public Health shall enter into an agreement regarding the purchase of a combination vaccine for the diseases: diphtheria, whooping cough, tetanus, polio, Hib and hepatitis B (a 6 component vaccine), for the National Vaccine Programme. The 6 component vaccine shall replace the current 5 component vaccine (diphtheria, whooping cough, tetanus, polio and Hib) and partly vaccine against hepatitis B for defined risk groups. The procurement is carried out on behalf of the Norwegian … Vis anskaffelsen »